Market Cap: $1.15B
SI
Savara Inc.
SVRA
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.15B
Open
$6.19
Prev. Close
$5.49
High
$6.265
Low
$6.03
Savara (Ticker: SVRA) has made significant strides with its drug candidate MOLBREEVI, as the U.S. Food and Drug Administration (FDA) accepts the biologics license application for this innovative treat…
Savara Pharmaceuticals, a company focused on developing therapies for rare respiratory diseases, announces that the FDA has extended the Priority Review of its Biologics License Application (BLA) for…
Savara's Position in the Evolving Landscape of Respiratory Therapeutics Savara, a company specializing in the development of novel therapies for respiratory diseases, is well-positioned to capitalize…
Savara Advances in Respiratory Therapeutics Amidst Market Optimism Savara, a clinical-stage biopharmaceutical company focused on developing innovative therapies for respiratory diseases, continues to…